CIDRAP-ASP Report – Outcomes Research & AMR: A Human-Centered Perspective on a Biosocial Problem

  15 December 2023

In the third of a three-part series, CIDRAP-ASP provides a socioeconomic perspective on AMR outcomes and cost-effectiveness research, advocating for greater consideration of social sciences perspectives, regional diversity and heterogeneity, and systems-based thinking in addressing the societal impacts and costs of AMR. 

Further reading: CIDRAP
Author(s): Francesca Chiara and Natalie Vestin
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed